Citalopram Hydrobromide

CAS 59729-32-7 17 current records 8 historicalSmall Molecule

Who holds supplier records for Citalopram Hydrobromide? 17 organisations hold a current record for Citalopram Hydrobromide: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 13 of them hold a valid EU Certificate of Suitability (12 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (13), China (1) and Denmark (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Citalopram Hydrobromide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/citalopram-hydrobromide

Reading the evidence

  • 17 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    13 of the 15 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (17)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Citalopram Hydrobromide. Country is the organisation's recorded country, not necessarily the manufacturing site.

India13China1Denmark1Country not recorded for 2
Need Citalopram Hydrobromide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (12)

Certificates of Suitability on the EDQM register for Citalopram Hydrobromide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HETERO DRUGS LIMITED HyderabadIN
CEP 2012-120 - Rev 06
Citalopram hydrobromide, CTP Process
Aug 2026—
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2021-462 - Rev 02
Citalopram hydrobromide, Process II
Jun 2026—
CIPLA LIMITED MumbaiIN
CEP 2009-012 - Rev 03
Citalopram hydrobromide
May 2026—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2010-037 - Rev 02
Citalopram hydrobromide, Micronised and non-micronised
Apr 2026Inspected May 2026
Italy
JUBILANT BIOSYS LIMITED MysuruIN
CEP 2010-379 - Rev 03
Citalopram hydrobromide, DGR process
Mar 2026—
VIRUPAKSHA ORGANICS LIMITED HyderabadIN
CEP 2021-437 - Rev 01
Citalopram hydrobromide
Oct 2025—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2009-043 - Rev 03
Citalopram hydrobromide
Jul 2025—
SHODHANA LABORATORIES PRIVATE LIMITED HyderabadIN
R1-CEP 2010-228 - Rev 02
Citalopram hydrobromide
Oct 2022—
WUXI JIDA PHARMACEUTICAL CO., LTD. JiangyinCN
R1-CEP 2011-214 - Rev 00
Citalopram hydrobromide
Sept 2017—
NATCO PHARMA LIMITED HyderabadIN
R1-CEP 2009-390 - Rev 01
Citalopram hydrobromide
Feb 2017—
H. Lundbeck A/S ValbyDK
R1-CEP 2010-222 - Rev 00
Citalopram hydrobromide
Jan 2017—
IPCA Laboratories Limited MumbaiIN
R1-CEP 2010-296 - Rev 00
Citalopram hydrobromide
Dec 2016—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (8)

Organisations whose Type II DMFs for Citalopram Hydrobromide are no longer active. These show a past filing, not current supply.

Show all 8 historical records
  • JIANGSU JIWA RINTECH PHARMACEUTICAL CO LTD
    Inactive DMF 20094 · filed Dec 2006
  • ESTEVE QUIMICA SA
    Inactive DMF 17511 · filed Jul 2004
  • RANBAXY LABORATORIES LTD
    Inactive DMF 17334 · filed Apr 2004
  • HEUMANN PHARMA GMBH
    Inactive DMF 17104 · filed Jan 2004
  • India · Inactive DMF 16788, 16979 · filed Nov 2003
  • MYLAN LABORATORIES LTD
    Inactive DMF 16961 · filed Nov 2003
  • Finland · Inactive DMF 16700 · filed Jul 2003
  • Japan · Inactive DMF 15836 · filed Jan 2002

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Citalopram Hydrobromide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200781).

Chemical identity

IUPAC name
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromide
Canonical SMILES
CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.Br
InChIKey
WIHMBLDNRMIGDW-UHFFFAOYSA-N
Synonyms
Celexa, Cipramil, Citalopram (as hydrobromide), Citalopram hbr, Citalopram hydrobromide, LU 10-171-B, LU-10-171-B, NSC-758684, Paxoran, Seropram, Elopram, Perrigo citalopram

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin Reuptake Inhibitor
Mechanism of action
Serotonin Uptake Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Citalopram Hydrobromide?

17 organisations hold an active US FDA Type II Drug Master File or a CEP for Citalopram Hydrobromide: APITORIA PHARMA PRIVATE LTD (India), Hetero Drugs Limited (India), JUBILANT BIOSYS LTD (India), Cipla Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), Natco Pharma (India), VIRUPAKSHA ORGANICS LTD (India) and WUXI JIDA PHARMACEUTICAL CO LTD, and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Citalopram Hydrobromide Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 16850, 19588), Hetero Drugs Limited (DMF 17979, 25088), JUBILANT BIOSYS LTD (DMF 15587, 20013), Cipla Limited (DMF 15813, 16553), MATRIX PHARMACORP PRIVATE LTD (DMF 21165), Natco Pharma (DMF 17185), VIRUPAKSHA ORGANICS LTD (DMF 36925) and WUXI JIDA PHARMACEUTICAL CO LTD (DMF 23979) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Citalopram Hydrobromide records mean?

8 organisations have only inactive Type II DMFs for Citalopram Hydrobromide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Citalopram Hydrobromide have a European Certificate of Suitability?

Yes. 13 organisations hold a valid CEP for Citalopram Hydrobromide on the EDQM register, including HETERO DRUGS LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), CIPLA LIMITED Mumbai (IN), ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou (CN), JUBILANT BIOSYS LIMITED Mysuru (IN) and VIRUPAKSHA ORGANICS LIMITED Hyderabad (IN) and 6 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Citalopram Hydrobromide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Citalopram Hydrobromide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.